HTR1B: 5-hydroxytryptamine receptor 1B
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
G protein-coupled receptor for 5-hydroxytryptamine (serotonin).
- Drugs that act on it: 12
- With a US drug page: 5
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Almotriptan | Approved | Serotonin 1b (5-HT1b) receptor agonist | Agonist | — |
| Eletriptan | Approved | Serotonin 1b (5-HT1b) receptor agonist | Agonist | — |
| Frovatriptan | Approved | Serotonin 1b (5-HT1b) receptor agonist | Agonist | — |
| Naratriptan | Approved | Serotonin 1b (5-HT1b) receptor agonist | Agonist | — |
| Zolmitriptan | Approved | Serotonin 1b (5-HT1b) receptor agonist | Agonist | — |
| Donitriptan | — | Serotonin 1b (5-HT1b) receptor agonist | Agonist | — |
| Elzasonan | — | Serotonin 1b (5-HT1b) receptor antagonist | Antagonist | — |
| Ergoloid | — | Serotonin 1b (5-HT1b) receptor agonist | Agonist | — |
| GSK163090 | — | Serotonin 1b (5-HT1b) receptor antagonist | Antagonist | — |
| Rizatriptan | — | Serotonin 1b (5-HT1b) receptor agonist | Agonist | Boxed warning |
| Sumatriptan | — | Serotonin 1b (5-HT1b) receptor agonist | Agonist | — |
| Trelanserin | — | Serotonin 1b (5-HT1b) receptor antagonist | Antagonist | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Schizophrenia
- 0.61
- Post operative nausea and vomiting
- 0.48
- Cardiovascular disorder
- 0.47
- Mathematical ability
- 0.47
- Obesity disorder
- 0.47
- Smoking initiation
- 0.42
- Psychotic disorder
- 0.39
Genes and Related Targets
Complexes and families that share a gene with this target- Genes
- HTR1B
- Related
- Serotonin (5-HT) receptor
Drugs and mechanisms are from ChEMBL CHEMBL1898 (CC BY-SA 3.0). Gene name, function (UniProt P28222, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets